MHY908
MHY908 is a potent dual agonist of PPARα and PPARγ. MHY908 also inhibits melanogenesis through inhibition of mushroom tyrosinase activity.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1393371-39-5
- Fòrmula: C17H14ClNO3S
- Peso molecular:347.82
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-N2736
3′,4′,7-Trihydroxyflavone -
HY-17356
Fenofibrate -
HY-50935
Troglitazone -
HY-113327
1,3,7-Trimethyluric acid -
HY-N2302
Fucoxanthin -
HY-B0760
Fenofibric acid -
HY-101988S
Prostaglandin D2-d4 -
HY-17356R
Fenofibrate (Standard) -
HY-N2853
D-α-Tocopherylquinone -
HY-19618
BRD3308 -
HY-B0760R
Fenofibric acid (Standard) -
HY-128135
MHY 553
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 1393371-39-5
-
Peso molecular 347.82
-
Fòrmula C17H14ClNO3S
-
SMILES
CC(OC1=CC=C(C=C1)C2=NC3=CC(Cl)=CC=C3S2)(C(O)=O)C
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Park MH, et al. Potent anti-diabetic effects of MHY908, a newly synthesized PPAR α/γ dual agonist in db/db mice. PLoS One. 2013 Nov 14;8(11):e78815. [Content Brief]
[2]. Park MH, et al. Inhibition of melanogenesis by 2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2-methylpropanoic acid (MHY908). Arch Pharm Res. 2015 Apr;38(4):505-11. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
MHY908 Related Classifications
HY-117761 Related Classifications
Powered by Bioz